These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
471 related articles for article (PubMed ID: 25652448)
1. SERCA1 overexpression minimizes skeletal muscle damage in dystrophic mouse models. Mázala DA; Pratt SJP; Chen D; Molkentin JD; Lovering RM; Chin ER Am J Physiol Cell Physiol; 2015 May; 308(9):C699-709. PubMed ID: 25652448 [TBL] [Abstract][Full Text] [Related]
2. The role of proteases in excitation-contraction coupling failure in muscular dystrophy. Mázala DA; Grange RW; Chin ER Am J Physiol Cell Physiol; 2015 Jan; 308(1):C33-40. PubMed ID: 25298424 [TBL] [Abstract][Full Text] [Related]
3. Can't live with or without it: calcium and its role in Duchenne muscular dystrophy-induced muscle weakness. Focus on "SERCA1 overexpression minimizes skeletal muscle damage in dystrophic mouse models". Cheng AJ; Andersson DC; Lanner JT Am J Physiol Cell Physiol; 2015 May; 308(9):C697-8. PubMed ID: 25740154 [No Abstract] [Full Text] [Related]
4. Alterations in Notch signalling in skeletal muscles from mdx and dko dystrophic mice and patients with Duchenne muscular dystrophy. Church JE; Trieu J; Chee A; Naim T; Gehrig SM; Lamon S; Angelini C; Russell AP; Lynch GS Exp Physiol; 2014 Apr; 99(4):675-87. PubMed ID: 24443351 [TBL] [Abstract][Full Text] [Related]
5. Contractile efficiency of dystrophic mdx mouse muscle: in vivo and ex vivo assessment of adaptation to exercise of functional end points. Capogrosso RF; Mantuano P; Cozzoli A; Sanarica F; Massari AM; Conte E; Fonzino A; Giustino A; Rolland JF; Quaranta A; De Bellis M; Camerino GM; Grange RW; De Luca A J Appl Physiol (1985); 2017 Apr; 122(4):828-843. PubMed ID: 28057817 [TBL] [Abstract][Full Text] [Related]
6. Truncated dystrophin ameliorates the dystrophic phenotype of mdx mice by reducing sarcolipin-mediated SERCA inhibition. Tanihata J; Nagata T; Ito N; Saito T; Nakamura A; Minamisawa S; Aoki Y; Ruegg UT; Takeda S Biochem Biophys Res Commun; 2018 Oct; 505(1):51-59. PubMed ID: 30236982 [TBL] [Abstract][Full Text] [Related]
7. Xanthine oxidase is hyper-active in Duchenne muscular dystrophy. Lindsay A; McCourt PM; Karachunski P; Lowe DA; Ervasti JM Free Radic Biol Med; 2018 Dec; 129():364-371. PubMed ID: 30312761 [TBL] [Abstract][Full Text] [Related]
13. Cathelicidin-related antimicrobial peptide mediates skeletal muscle degeneration caused by injury and Duchenne muscular dystrophy in mice. Choi MC; Jo J; Lee M; Park J; Yao TP; Park Y J Cachexia Sarcopenia Muscle; 2022 Dec; 13(6):3091-3105. PubMed ID: 36059045 [TBL] [Abstract][Full Text] [Related]
14. Utrophin haploinsufficiency does not worsen the functional performance, resistance to eccentric contractions and force production of dystrophic mice. Boulanger Piette A; Hamoudi D; Marcadet L; Kyomi Labelle F; Ovidiu David R; Bossé S; Argaw A; Frenette J PLoS One; 2018; 13(6):e0198408. PubMed ID: 29879154 [TBL] [Abstract][Full Text] [Related]
15. Pharmacological activation of SERCA ameliorates dystrophic phenotypes in dystrophin-deficient mdx mice. Nogami K; Maruyama Y; Sakai-Takemura F; Motohashi N; Elhussieny A; Imamura M; Miyashita S; Ogawa M; Noguchi S; Tamura Y; Kira JI; Aoki Y; Takeda S; Miyagoe-Suzuki Y Hum Mol Genet; 2021 May; 30(11):1006-1019. PubMed ID: 33822956 [TBL] [Abstract][Full Text] [Related]
16. Muscle-specific overexpression of IGF-I improves E-C coupling in skeletal muscle fibers from dystrophic mdx mice. Schertzer JD; van der Poel C; Shavlakadze T; Grounds MD; Lynch GS Am J Physiol Cell Physiol; 2008 Jan; 294(1):C161-8. PubMed ID: 17989207 [TBL] [Abstract][Full Text] [Related]
17. Pannexin 1 dysregulation in Duchenne muscular dystrophy and its exacerbation of dystrophic features in mdx mice. Freeman E; Langlois S; Leyba MF; Ammar T; Léger Z; McMillan HJ; Renaud JM; Jasmin BJ; Cowan KN Skelet Muscle; 2024 Apr; 14(1):8. PubMed ID: 38671506 [TBL] [Abstract][Full Text] [Related]